dei |
Entity Common Stock, Shares Outstanding |
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
View
|
us-gaap |
Deferred Tax Assets, Operating Loss Carryforwards |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. |
View
|
us-gaap |
Earnings Per Share, Basic and Diluted |
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. |
View
|
us-gaap |
Proceeds from Related Party Debt |
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
View
|
us-gaap |
Professional Fees |
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. |
View
|
us-gaap |
Retained Earnings (Accumulated Deficit) |
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
View
|
us-gaap |
Stockholders' Equity Attributable to Parent |
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
View
|
dei |
Entity Public Float |
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. |
View
|
us-gaap |
Accounts Payable and Accrued Liabilities, Current |
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
View
|
us-gaap |
Additional Paid in Capital |
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
View
|
us-gaap |
Assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Cash and Cash Equivalents, at Carrying Value |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash and Cash Equivalents, Period Increase (Decrease) |
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. |
View
|
us-gaap |
Common Stock, Par or Stated Value Per Share |
Face amount or stated value per share of common stock. |
View
|
us-gaap |
Common Stock, Shares Authorized |
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Common Stock, Shares, Issued |
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
View
|
us-gaap |
Common Stock, Shares, Outstanding |
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. |
View
|
us-gaap |
Common Stock, Value, Issued |
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
View
|
us-gaap |
Deferred Tax Assets, Valuation Allowance |
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. |
View
|
us-gaap |
Due to Related Parties, Current |
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). |
View
|
us-gaap |
General and Administrative Expense |
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
View
|
us-gaap |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount |
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount |
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. |
View
|
us-gaap |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
View
|
us-gaap |
Increase (Decrease) in Inventories |
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
View
|
us-gaap |
Inventory, Net |
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
View
|
us-gaap |
Inventory Write-down |
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. |
View
|
us-gaap |
Liabilities |
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. |
View
|
us-gaap |
Liabilities and Equity |
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
View
|
us-gaap |
Net Cash Provided by (Used in) Financing Activities, Continuing Operations |
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
View
|
us-gaap |
Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. |
View
|
us-gaap |
Net Income (Loss) Attributable to Parent |
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
View
|
us-gaap |
Operating Expenses |
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
View
|
us-gaap |
Operating Loss Carryforwards |
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. |
View
|
us-gaap |
Proceeds from Issuance of Common Stock |
The cash inflow from the additional capital contribution to the entity. |
View
|
us-gaap |
Stock Issued During Period, Shares, New Issues |
Number of new stock issued during the period. |
View
|
us-gaap |
Stock Issued During Period, Value, New Issues |
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic and Diluted |
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). |
View
|